METAvivor
Eligibility
- MD or PhD within 10 years of terminal degree.
- Within 6 years of first non-tenured position.
Description
METAvivor funds research that specifically addresses the mechanistic understanding, diagnosis, and/or treatment of metastatic breast cancer.
Anticipated deadline: March 2026
Keywords:
breast cancer, metastasis
Award amount:
$200,000